A Phase 1 Study to Evaluate the Adhesion, Pharmacokinetics (PK) and Safety of a Seven-Day Application of Donepezil Transdermal Delivery System (TDS) in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 11 Jan 2017 Status changed from recruiting to completed.
- 11 Jan 2017 Planned number of patients changed from 48 to 86.
- 26 Jul 2016 Oral sub-study group has been added to the treatment regimen and primary end point has been added to obtain PK profile as per Australian New Zealand Clinical Trials Registry record.